Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × ceritinib × Lymphoid × Clear all

Status

Terminated 2 Withdrawn 1 Completed 1 Available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Lymphoid 1

Conditions

Lymphoma, Large-Cell, Anaplastic 1 Granuloma, Plasma Cell 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

venetoclax 1 tisagenlecleucel 1 tipifarnib 1 selinexor 1 ceritinib 1 brexucabtagene autoleucel 1 axicabtagene ciloleucel 1 Proton Pump Inhibitors 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05100134 2025-12-09

Managed Access Programs for LDK378, Ceritinib

Novartis

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡